|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/5377 | (2006.01) |
| A61P 17/00 | (2006.01) | ||
| A61K 9/00 | (2006.01) |
| (11) | Number of the document | 3592355 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18764980.1 |
| Date of filing the European patent application | 2018-03-12 | |
| (97) | Date of publication of the European application | 2020-01-15 |
| (45) | Date of publication and mention of the grant of the patent | 2025-12-10 |
| (46) | Date of publication of the claims translation | 2026-02-25 |
| (86) | Number | PCT/US2018/021929 |
| Date | 2018-03-12 |
| (87) | Number | WO 2018/165647 |
| Date | 2018-09-13 |
| (30) | Number | Date | Country code |
| 201762469889 P | 2017-03-10 | US |
| (72) |
KWAN, Min-Fun Rudolf , US
LAU, Johnson Yiu-Nam , US
KRAMER, E. Douglas , US
CUTLER, David Lawrence , US
FANG, Jane , US
|
| (73) |
ATNX SPV, LLC ,
161 Bay Street, Suite 5000, Toronto, Ontario M5J 2S1,
CA
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | KX2-391/KX-01, skirtas naudoti aktininės keratozės gydymui |
| KX2-391/KX-01 FOR USE IN THE TREATMENT OF ACTINIC KERATOSIS |
| Payment date | Validity (years) | Amount | |
| 2026-02-18 | 9 | 208.00 EUR |
| 2027-03-12 |